The neuroendocrine component of the AL index, which is an indirect measure of inflammatory-hormonal activation, was found to be significantly higher in patients with the disease (both in the entire study group and in the subgroup with acromegaly) than in healthy subjects when IGF-I levels were included in the calculations. This evidence concerns the gene IGF1 and acromegaly.